Article
Genotyping and Prevalence of Pyrazinamide- and Moxifloxacin-Resistant Tuberculosis in China, 2000 to 2010.
Antimicrobial agents and chemotherapy - 1 Feb 2017
Pang Yu, Zhang Zhijian, Wang Yufeng, Wang Shengfen, Song Yuanyuan, Zhao Bing, Zhou Yang, Ou Xichao, Li Qiang, Xia Hui, Zheng Yang, Fang Xiangqun, Zhao Yanlin
Abstract excerpt
We investigated the prevalence, trends, and risk factors for pyrazinamide (PZA) and moxifloxacin (MOX) resistance among tuberculosis (TB) cases in China and also analyzed the population structure of Mycobacterium tuberculosis strains. All the M. tuberculosis strains enrolled in this study were collected from the national TB prevalence surveys. Each strain was genotyped by analyzing the regions of RD105 and IS6110...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
